Skip to main content
. 2023 May 24;24(11):9204. doi: 10.3390/ijms24119204

Figure 9.

Figure 9

Assessment of ARSA (yellow) expression in different regions of nervous tissue in the control group of animals (AF) and in experimental groups 1 and 2 on day 35 after the intrathecal (A1F1) and intravenous (A2F2) administration of AAV9-ARSA, respectively. Nuclei were stained with DAPI (blue). Scale bar: 50 µm. Control—control group of animals, IT AAV9-ARSA—intrathecal administration of AAV9-ARSA, IV AAV9-ARSA—intravenous administration of AAV9-ARSA vector.